IC
SNDX icon

IEQ Capital’s Syndax Pharmaceuticals SNDX Stock Holding History

IEQ Capital’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56M Buy
109,623
+9,747
+10% +$212K 0.01% 678
2025
Q4 		$2.1M Buy
99,876
+44,672
+81% +$779K 0.01% 774
2025
Q3 		$849K Buy
55,204
+42,044
+319% +$550K ﹤0.01% 1072
2025
Q2 		$123K Sell
13,160
-46,050
-78% -$507K ﹤0.01% 1692
2025
Q1 		$727K Buy
+59,210
New +$835K 0.01% 843

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

IEQ Capital's SNDX Position: Q1 2026 in Review

IEQ Capital increased its Syndax Pharmaceuticals (SNDX) stake by 9.8% in Q1 2026, buying an estimated $212K and bringing the position to 109,623 shares worth $2.56M. The position accounts for 0.01% of the portfolio, ranked #678.

IEQ Capital first reported a position in SNDX in Q1 2025 and has held it in 5 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • IEQ Capital held 109,623 shares of Syndax Pharmaceuticals worth $2.56M as of Q1 2026.
  • IEQ Capital bought 9,747 Syndax Pharmaceuticals shares in Q1 2026, an estimated $212K.
  • Syndax Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q1 2026, its #678 holding.
  • IEQ Capital first reported a position in Syndax Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.